MAIA’s lung cancer therapy 99% more likely to improve OS over chemo alone
A treatment for patients living with advanced non-small cell lung cancer (NSCLC) who failed two or more standard-of-care (SOC) options could extend overall survival (OS) to 16.9 months according to ...
Future Market Insights8d
Generic Oncology Drug Industry in Europe and MENA Poised for Substantial Growth, Reaching USD 8.2 Billion by 2033 soar at a 2.1% CAGR
A new wave of hope is sweeping across Europe and MENA for millions of cancer patients seeking affordable and effective treatment options. The rise of generic oncology drugs is offering a much-needed ...
Sky20d
Germany: Europe's largest economy is facing a third consecutive year of recession
The most important European data release was the confirmation from Germany that, during 2024, its economy contracted for the second consecutive year. Europe's largest economy shrank by 0.2% during ...
Associated Press22d
Germany’s economy shrank for the second consecutive year in 2024
Copyright 2025 The Associated Press. All Rights Reserved. Trucks and cars move along on a highway in Frankfurt, Germany, Wednesday, Jan. 15, 2025. (AP Photo/Michael ...
Seeking Alpha22d
Regeneron: Phase III Success In Skin Cancer For Libtayo
Regeneron stock has trended bearishly since August, but growth in LIBTAYO and DUPIXENT offers a promising outlook, prompting a BUY rating. EYLEA HD's success mitigates biosimilar competition ...
Pharmabiz22d
Regeneron announces adjuvant Libtayo significantly improves DFS after surgery in high-risk CSCC in phase 3 trial
Regeneron Pharmaceuticals, Inc. announced positive results from the phase 3 C-POST trial, which demonstrated that adjuvant treatment with PD-1 inhibitor Libtayo (cemiplimab) led to a statistically ...
Business Insider22d
Regeneron Buy Rating Supported by Eylea HD Launch, Dupixent Expansion, and Libtayo Success
Additionally, the success of Libtayo in the treatment of cutaneous squamous cell carcinoma further supports the optimistic outlook. These factors collectively contribute to the positive assessment ...
The New York Times22d
Germany’s Economy Shrank Last Year. Here’s How Politicians Plan to Revive It.
By Melissa Eddy Germany’s economic output shrank for a second straight year in 2024, data released Wednesday showed. How to revive it has become a central issue as voters prepare to go to the ...
Reuters22d
Germany says it has found no more foot-and-mouth cases
BERLIN, Jan 15 (Reuters) - Germany has not found any further cases of foot-and-mouth disease, agriculture minister Cem Oezdemir said on Wednesday, adding that experts were working day and night to ...
PMLiVE22d
Regeneron shares positive phase 3 results for Libtayo in high-risk skin cancer
Regeneron Pharmaceuticals has shared positive results from a late-stage trial of Libtayo (cemiplimab) in patients with high-risk cutaneous squamous cell carcinoma (CSCC) after surgery. The phase 3 ...
Politico Europe23d
Germany’s likely next chancellor vows to put economy before climate
BERLIN — Germany's likely next chancellor, Friedrich Merz, has vowed to restore Germany’s industrial competitiveness by putting climate policies on the back burner. Germany’s economic policies have ...